According to Zevra Therapeutics's latest financial reports the company's current EPS (TTM) is 0,41ย โฌ. In 2016 the company made an earnings per share (EPS) of -16,63ย โฌ an increase over its 2015 EPS that were of -58,49ย โฌ.